< Back to situations

Monitor this situation.

[SITUATION] · [QUIET] · [BUSINESS]

2 clusters · 9 sources · 25 days · First seen · Last updated

Walmart federal opioid prescription settlement

Overview

Walmart has agreed to a $50 million settlement to resolve a federal lawsuit brought by the U.S. Department of Justice and the Drug Enforcement Administration. The litigation, initiated in 2020, alleged that the company’s pharmacies illegally filled thousands of invalid prescriptions for opioids and other controlled substances between 2013 and the present.

Government allegations claimed that Walmart’s compliance team was aware of certain doctors operating ‘pill mills’ but failed to act, allegedly prioritizing sales over investigating suspicious activity. In response to the settlement, Walmart will enter into a memorandum of agreement with the DEA, which includes establishing a hotline for reporting illegal dispensing, monitoring pharmacy patterns, and implementing processes to evaluate prescribers suspected of illegal activity.

Entities

43 U.S. states and territories · Walmart · Drug Enforcement Administration · U.S. Department of Justice · Stanley Woodard

Claims

What the coverage asserts, and how many sources carry each claim.

Timeline

  1. 15 days ago

    [BUSINESS] 8 sources
    Walmart to pay $50 million to settle federal opioid prescription lawsuit

    Walmart will pay $50 million to settle federal allegations that its pharmacies filled invalid opioid prescriptions despite internal warnings and red flags.

  2. about 1 month ago

    [BUSINESS] 4 sources
    Sandoz to Pay $450 Million in Settlement with 43 U.S. States

    Sandoz will pay about $450 million to settle antitrust claims with 43 U.S. states and a reseller group, ending most lawsuits without admitting wrongdoing and keeping its outlook unchanged.

Sources

aljazeera.com · arise.tv · finanzen.at · finchannel.com · it-boltwise.de · quepasamedia.com · smartmusic.com · talkbusiness.net · wbrz.com